These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24168499)

  • 1. The expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy.
    Shroff S; Overman MJ; Rashid A; Shroff RT; Wang H; Chatterjee D; Katz MH; Lee JE; Wolff RA; Abbruzzese JL; Fleming JB; Wang H
    Arch Pathol Lab Med; 2013 Nov; 137(11):1619-26. PubMed ID: 24168499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
    Zenali M; Overman MJ; Rashid A; Broaddus RB; Wang H; Katz MH; Fleming JB; Abbruzzese JL; Wang H
    Hum Pathol; 2013 Dec; 44(12):2792-8. PubMed ID: 24139211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Foo WC; Rashid A; Wang H; Katz MH; Lee JE; Pisters PW; Wolff RA; Abbruzzese JL; Fleming JB; Wang H
    Hum Pathol; 2013 Jun; 44(6):1024-30. PubMed ID: 23260327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.
    Yun SP; Seo HI
    BMC Gastroenterol; 2015 Nov; 15():165. PubMed ID: 26603157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater.
    Murakami T; Matsuyama R; Ueda M; Mochizuki Y; Homma Y; Kameda K; Yazawa K; Izumisawa Y; Fukushima T; Kamimukai N; Yoshida K; Kamiya N; Hoffman RM; Endo I
    World J Surg Oncol; 2019 Aug; 17(1):140. PubMed ID: 31399104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis.
    Winter JM; Cameron JL; Olino K; Herman JM; de Jong MC; Hruban RH; Wolfgang CL; Eckhauser F; Edil BH; Choti MA; Schulick RD; Pawlik TM
    J Gastrointest Surg; 2010 Feb; 14(2):379-87. PubMed ID: 19911239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection.
    Qiao QL; Zhao YG; Ye ML; Yang YM; Zhao JX; Huang YT; Wan YL
    World J Surg; 2007 Jan; 31(1):137-43; discussion 144-6. PubMed ID: 17171495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors.
    Iacono C; Verlato G; Zamboni G; Scarpa A; Montresor E; Capelli P; Bortolasi L; Serio G
    J Gastrointest Surg; 2007 May; 11(5):578-88. PubMed ID: 17468917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors in adenocarcinoma of the ampulla of Vater].
    Fernández Aceñero MJ; Martínez Useros J; Díez-Valladares L; Ortega-Medina L; Pérez Aguirre E; de la Serna Esteban S; García Botella S; Díaz Del Arco C
    Rev Esp Patol; 2018; 51(4):210-215. PubMed ID: 30269771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
    Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
    Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic Predictors of Survival and Recurrence in Resected Ampullary Adenocarcinoma: International Multicenter Cohort Study.
    Moekotte AL; Lof S; Van Roessel S; Fontana M; Dreyer S; Shablak A; Casciani F; Mavroeidis VK; Robinson S; Khalil K; Gradinariu G; Mowbray N; Al-Sarireh B; Fusai GK; Roberts K; White S; Soonawalla Z; Jamieson NB; Salvia R; Besselink MG; Abu Hilal M
    Ann Surg; 2020 Dec; 272(6):1086-1093. PubMed ID: 30628913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of histological blood vessel invasion in patients with ampullary adenocarcinoma.
    Kawaguchi T; Ochiai T; Ikoma H; Inoue K; Morimura R; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Okamoto K; Fujiwara H; Kokuba Y; Sonoyama T; Otsuji E
    Hepatogastroenterology; 2010; 57(104):1347-50. PubMed ID: 21443083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic and survival analysis of resected ampullary adenocarcinoma.
    Doepker MP; Thompson ZJ; Centeno BA; Kim RD; Wong J; Hodul PJ
    J Surg Oncol; 2016 Aug; 114(2):170-5. PubMed ID: 27158031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.
    Ohike N; Kim GE; Tajiri T; Krasinskas A; Basturk O; Coban I; Bandyopadhyay S; Morohoshi T; Goodman M; Kooby DA; Sarmiento JM; Adsay NV
    Am J Surg Pathol; 2010 Dec; 34(12):1731-48. PubMed ID: 21084962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very early recurrence following pancreaticoduodenectomy in patients with ampullary cancer.
    Park HM; Park SJ; Han SS; Hong SK; Hong EK; Kim SW
    Medicine (Baltimore); 2019 Nov; 98(44):e17711. PubMed ID: 31689805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in patients with operable ampullary carcinoma.
    Demirci NS; Erdem GU
    Bosn J Basic Med Sci; 2018 Aug; 18(3):268-274. PubMed ID: 29131967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas.
    Pomianowska E; Westgaard A; Mathisen Ø; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Jan; 20(1):233-41. PubMed ID: 22893118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma.
    Xia M; Overman MJ; Rashid A; Chatterjee D; Wang H; Katz MH; Fleming JB; Lee JE; Varadhachary GR; Wolff RA; Wang H
    Hum Pathol; 2015 Sep; 46(9):1315-22. PubMed ID: 26165226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma.
    Kim RD; Kundhal PS; McGilvray ID; Cattral MS; Taylor B; Langer B; Grant DR; Zogopoulos G; Shah SA; Greig PD; Gallinger S
    J Am Coll Surg; 2006 Jan; 202(1):112-9. PubMed ID: 16377504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical outcomes and prognostic factors for ampulla of Vater cancer.
    Choi SB; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
    Scand J Surg; 2011; 100(2):92-8. PubMed ID: 21737384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.